类有机物
胚状体
诱导多能干细胞
细胞生物学
细胞
胚胎干细胞
生物
生物化学
基因
遗传学
作者
Seungmi Ryu,Claire Weber,Pei‐Hsuan Chu,Ben Ernest,Vukasin M. Jovanovic,Tao Deng,Jaroslav Slamecka,Hyenjong Hong,Yogita Jethmalani,Hannah M. Baskir,Jason Inman,John Braisted,Marissa B. Hirst,Anton Simeonov,Ty C. Voss,Carlos A Tristan,Ilyas Singeç
出处
期刊:Biofabrication
[IOP Publishing]
日期:2023-11-16
卷期号:16 (1): 015016-015016
被引量:5
标识
DOI:10.1088/1758-5090/ad0d13
摘要
Abstract Embryoid bodies (EBs) and self-organizing organoids derived from human pluripotent stem cells (hPSCs) recapitulate tissue development in a dish and hold great promise for disease modeling and drug development. However, current protocols are hampered by cellular stress and apoptosis during cell aggregation, resulting in variability and impaired cell differentiation. Here, we demonstrate that EBs and various organoid models (e.g., brain, gut, kidney) can be optimized by using the small molecule cocktail named CEPT (chroman 1, emricasan, polyamines, trans-ISRIB), a polypharmacological approach that ensures cytoprotection and cell survival. Application of CEPT for just 24 h during cell aggregation has long-lasting consequences affecting morphogenesis, gene expression, cellular differentiation, and organoid function. Various qualification methods confirmed that CEPT treatment enhanced experimental reproducibility and consistently improved EB and organoid fitness as compared to the widely used ROCK inhibitor Y-27632. Collectively, we discovered that stress-free cell aggregation and superior cell survival in the presence of CEPT are critical quality control determinants that establish a robust foundation for bioengineering complex tissue and organ models.
科研通智能强力驱动
Strongly Powered by AbleSci AI